Quantitative Measurement of Functional Activity of the PI3K Signaling Pathway in Cancer

by Anja van de Stolpe
Published 2019-03-01

Circulating Tumor Cells: What Is in It for the Patient? A Vision towards the Future

by Anja van de Stolpe, Jaap M. J. den Toonder
Published 2014-05-01

Measurement of Cellular Immune Response to Viral Infection and Vaccination

by Wilbert Bouwman, Wim Verhaegh, Laurent Holtzer, Anja van de Stolpe
Published 2020-10-01

Wnt signaling in multiple myeloma: a central player in disease with therapeutic potential

by Ingrid Spaan, Reinier A. Raymakers, Anja van de Stolpe, Victor Peperzak
Published 2018-05-01

Multiple Myeloma Relapse Is Associated with Increased NFκB Pathway Activity and Upregulation of the Pro-Survival BCL-2 Protein BFL-1

by Ingrid Spaan, Anja van de Stolpe, Reinier A. Raymakers, Victor Peperzak
Published 2021-09-01

Signal Transduction Pathway Activity in High-Grade, Serous Ovarian Carcinoma Reveals a More Favorable Prognosis in Tumors with Low PI3K and High NF-κB Pathway Activity: A Novel App...

by Laura van Lieshout, Anja van de Stolpe, Phyllis van der Ploeg, David Bowtell, Joanne de Hullu, Jurgen Piek
Published 2020-09-01

Cytostretch, an Organ-on-Chip Platform

by Nikolas Gaio, Berend van Meer, William Quirós Solano, Lambert Bergers, Anja van de Stolpe, Christine Mummery, Pasqualina M. Sarro, Ronald Dekker
Published 2016-07-01

A Molecular Test for Quantifying Functional Notch Signaling Pathway Activity in Human Cancer

by Kirsten Canté-Barrett, Laurent Holtzer, Henk van Ooijen, Rico Hagelaar, Valentina Cordo’, Wim Verhaegh, Anja van de Stolpe, Jules P. P. Meijerink
Published 2020-10-01

ER and PI3K Pathway Activity in Primary ER Positive Breast Cancer Is Associated with Progression-Free Survival of Metastatic Patients under First-Line Tamoxifen

by Anieta M. Sieuwerts, Márcia A. Inda, Marcel Smid, Henk van Ooijen, Anja van de Stolpe, John W. M. Martens, Wim F. J. Verhaegh
Published 2020-03-01

ER and PI3K Pathway Activity in Primary ER Positive Breast Cancer Is Associated with Progression-Free Survival of Metastatic Patients under First-Line Tamoxifen

by Anieta M. Sieuwerts, M\u00e1rcia A. Inda, Marcel Smid, Henk van Ooijen, Anja van de Stolpe, John W. M. Martens, Wim F. J. Verhaegh
Published 2020-03-01

Heterogeneity in Signaling Pathway Activity within Primary and between Primary and Metastatic Breast Cancer

by Márcia A. Inda, Paul van Swinderen, Anne van Brussel, Cathy B. Moelans, Wim Verhaegh, Hans van Zon, Eveline den Biezen, Jan Willem Bikker, Paul J. van Diest, Anja van de Stolpe
Published 2021-03-01

RNA Based Approaches to Profile Oncogenic Pathways From Low Quantity Samples to Drive Precision Oncology Strategies

by Anja van de Stolpe, Wim Verhaegh, Jean-Yves Blay, Jean-Yves Blay, Cynthia X. Ma, Patrick Pauwels, Mark Pegram, Hans Prenen, Dirk De Ruysscher, Nabil F. Saba, Nabil F. Saba, Nabil F. Saba, Susan F. Slovin, Karen Willard-Gallo, Hatim Husain
Published 2021-02-01